早接种早保护！浙江HPV疫苗惠民延长至2026年 这些人群抓紧

Core Viewpoint - Zhejiang Province is implementing HPV vaccination initiatives to enhance public health and prevent related diseases, particularly cervical cancer, by providing subsidized access to the HPV vaccine for eligible populations [1][2]. Group 1: HPV Vaccination Initiatives - The HPV vaccination program in Zhejiang will offer subsidized access to the imported nine-valent HPV vaccine for females aged 9-26 and 35-45, as well as males aged 16-26, with the last dose being free of charge [1]. - The vaccination initiative has received positive social feedback, leading to an extension of the vaccination period to accommodate demand, with the first dose deadline set for September 30, 2026, in most cities [2]. - The program aims to provide protection for women beyond the national immunization age and includes male vaccination, thereby broadening the health care support system [2]. Group 2: HPV Infection and Prevention - HPV is a common infection with over 200 types, with high-risk types being responsible for approximately 98% of cervical cancer cases in Chinese women [3][4]. - The incidence of cervical cancer in China is rising, with nearly 150,000 new cases and 60,000 deaths reported in 2022, highlighting the importance of preventive measures such as vaccination [3]. - The World Health Organization recommends that girls aged 9-14, who have not yet engaged in sexual activity, are the primary target group for HPV vaccination to achieve optimal protection [3]. Group 3: Gender Considerations in HPV Vaccination - HPV infection rates show a "bimodal" distribution among women, with peaks at ages 17-24 and 40-44, indicating the need for vaccination across different age groups [4]. - Men are also significantly affected by HPV, with a lifetime infection rate of approximately 90%, and the vaccination of both genders is essential to reduce overall infection rates and associated health risks [5][6]. - The collaborative vaccination strategy for both genders is expected to lower HPV infection rates and reduce healthcare costs related to screening and treatment [5]. Group 4: Public Health Strategy and Accessibility - The clinical guidelines recommend prioritizing HPV vaccination for females aged 9-26, with a focus on girls aged 9-14, while also including males and older females in the vaccination strategy [6]. - Zhejiang's multi-faceted approach to promoting HPV vaccination reflects a commitment to public health and aims to establish a herd immunity barrier by making vaccinations more accessible and affordable [6].